Evidence that statins protect renal function during endovascular repair of AAAs

European Journal of Vascular and Endovascular Surgery

Volumn 40, Issue 5, 2010, Pages 608-615

  Moulakakis, K G ^a   Matoussevitch, V ^a   Borgonio, A ^a   Gawenda, M ^a   Brunkwall, J ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Abdominal aortic aneurysm; Endovascular; HMG CoA reductase inhibitors; Renal function; Statins

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; MEVINOLIN; NITRATE; PRAVASTATIN; SIMVASTATIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; INTRARENAL STENT FIXATION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY INFARCTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL PROTECTION; SUPRARENAL STENT FIXATION;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78649335299     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.05.006     Document Type: Conference Paper

References (43)

1. I. Syk, J. Brunkwall, K. Ivancev, B. Lindblad, A. Montgomery, and E. Wellander Postoperative fever, bowel ischaemia and cytokine response to abdominal aortic aneurysm repair-a comparison between endovascular and open surgery Eur J Vasc Endovasc Surg 15 1998 398 405
2. S.R. Walker, S.W. Yusuf, P.W. Wenham, and B.R. Hopkinson Renal complications following endovascular repair of abdominal aortic aneurysms J Endovasc Surg 5 1998 318 322
3. P. Cuypers, A. Nevelsteen, J. Buth, J. Hamming, L. Stockx, and H. Lacroix Complications in the endovascular repair of abdominal aortic aneurysms: a risk factor analysis Eur J Vasc Endovasc Surg 18 1999 245 252
4. J.S. Lindholt Radiocontrast induced nephropathy Eur J Vasc Endovasc Surg 25 2003 296 304
5. A. Asif, R.A. Preston, and D. Roth Radiocontrast-induced nephropathy Am J Ther 10 2003 137 147
6. R. Wald, S.S. Waikar, O. Liangos, B.J. Pereira, G.M. Chertow, and B.L. Jaber Acute renal failure after endovascular vs. open repair of abdominal aortic aneurysm J Vasc Surg 43 2006 460 466
7. S. Hosaka, K. Kamiya, S. Akimoto, O. Suzuki, M. Kobayashi, and T. Matsukawa Atheromatous embolization as a cause of postoperative renal dysfunction in infrarenal aortic reconstructive surgery Nippon Geka Gakkai Zasshi 95 1994 109 115
8. S.R. Walsh, J.R. Boyle, A.G. Lynch, U. Sadat, J.P. Carpenter, and T.Y. Tang Suprarenal endograft fixation and medium-term renal function: systematic review and meta-analysis J Vasc Surg 47 2008 1364 1370
9. M. Malina, M. Lindh, K. Ivancev, B. Frennby, B. Lindblad, and J. Brunkwall The effect of endovascular aortic stents placed across the renal arteries Eur J Vasc Endovasc Surg 13 1997 207 213
10. M. Malina, J. Brunkwall, K. Ivancev, M. Lindh, B. Lindblad, and B. Risberg Renal arteries covered by aortic stents: clinical experience from endovascular grafting of aortic aneurysms Eur J Vasc Endovasc Surg 14 1997 109 113
11. P. Calabr, and E.T. Yeh The pleiotropic effects of statins Curr Opin Cardiol 20 2005 541 546
12. V. Lahera, M. Goicoechea, S.G. de Vinuesa, M. Miana, N. de lasHeras, and V. Cachofeiro Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins Curr Med Chem. 14 2007 243 248
13. E.L. Chaikof, J.D. Blankensteijn, P.L. Harris, G.H. White, C.K. Zarins, and V.M. Bernhard Reporting standards for endovascular aortic aneurysm repair J Vasc Surg 35 2002 1048 1060
14. E.L. Chaikof, M.F. Fillinger, J.S. Matsumura, R.B. Rutherford, G.H. White, and J.D. Blankensteijn Indentifying and grading factors that modify the outcome of endovascular aortic aneurysm repair J Vasc Surg 35 2002 1061 1066
15. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
16. P. Alric, R.J. Hinchliffe, M.C. Picot, B.D. Braithwaite, S.T. MacSweeney, and P.W. Wenham Long-term renal function following endovascular aneurysm repair with infrarenal and suprarenal aortic stent-grafts J Endovasc Ther 10 2003 397 405
17. W. Stelter, T. Umscheid, and P. Ziegler Three-year experience with modular stent-graft devices for endovascular AAA treatment J Endovasc Surg 4 1997 362 369
18. A.E. Durazzo, F.S. Machado, D.T. Ikeoka, C. De Bernoche, M.C. Monachini, and P. Puech-Leão Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial J Vasc Surg 39 2004 967 975
19. D. Poldermans, J.J. Bax, M.D. Kertai, B. Krenning, C.M. Westerhout, and A.F. Schinkel Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
20. P.K. Lindenauer, P. Pekow, K. Wang, B. Gutierrez, and E.M. Benjamin Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2004 2092 2099
21. H.H. Feringa, S.E. Karagiannis, M. Chonchol, R. Vidakovic, P.G. Noordzij, and A. Elhendy Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors J Am Soc Nephrol 18 2007 1872 1879
22. R.H. Samson The role of statin drugs in the management of the peripheral vascular patient Vasc Endovascular Surg 42 2008 352 366
23. O. Schouten, N.F. Kok, E. Boersma, J.J. Bax, H.H. Feringa, and R. Vidakovic Effects of statins on renal function after aortic cross clamping during major vascular surgery Am J Cardiol 97 2006 1383 1385
24. P. Libby, and M. Aikawa Mechanisms of plaque stabilization with statins Am J Cardiol 91 2003 4B 8B
25. F. Akdim, S.I. van Leuven, J.J. Kastelein, and E.S. Stroes Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Curr Pharm Des 13 2007 1003 1012
26. F. Wiesbauer, C. Kaun, G. Zorn, G. Maurer, K. Huber, and J. Wojta HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins Br J Pharmacol 135 2002 284 292
27. M. Eto, and T.F. Luscher Modulation of coagulation and fibrinolytic pathways by statins Endothelium 10 2003 35 41
28. M.M. Thompson, J. Smith, A.R. Naylor, A. Nasim, R.D. Sayers, and J.R. Boyle Microembolization during endovascular and conventional aneurysm repair J Vasc Surg 25 1997 179 186 (Pubitemid 27081625)
29. R.W. Katzberg Contrast medium-induced nephrotoxicity: which pathway? Radiology 235 2005 752 755
30. G.L. Bakris, N. Lass, A.O. Gaber, J.D. Jones, and J.C. Burnett Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals Am J Physiol 258 1990 F115 F120
31. R. Baliga, N. Ueda, P.D. Walker, and S.V. Shah Oxidant mechanisms in toxic acute renal failure Am J Kidney Dis 29 1997 465 477
32. M. Tepel, M. van derGiet, C. Schwarzfeld, U. Laufer, D. Liermann, and W. Zidek Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
33. R.S. Rosenson Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities Atherosclerosis 173 2004 1 12
34. J. Davignon, R.F. Jacob, and R.P. Mason The antioxidant effects of statins Coron Artery Dis 15 2004 251 258
35. S. Kalliafas, S.J. Travis, J. Macierewicz, S.W. Yusuf, S.C. Whitaker, and I. Davidson Intrarenal color duplex examination of aortic endograft patients with suprarenal stents J EndovascSurg 8 2001 592 596
36. R. Agarwal Effects of statins on renal function Am J Cardiol 97 2006 748 755
37. G.F. Strippoli, S.D. Navaneethan, D.W. Johnson, V. Perkovic, F. Pellegrini, and A. Nicolucci Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 2008 645 651
38. M. Rahman, C. Baimbridge, B.R. Davis, J. Barzilay, J.N. Basile, M.A. Henriquez ALLHAT Collaborative Research Group Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Am J Kidney Dis 52 2008 412 424
39. S. Sandhu, N. Wiebe, L.F. Fried, and M. Tonelli Statins for improving renal outcomes: a meta-analysis J Am Soc Nephrol 17 2006 2006 2016
40. M. Tonelli, L. Moyé, F.M. Sacks, T. Cole, and G.C. Curhan Cholesterol and Recurrent Events Trial Investigators. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 2003 1605 1613
41. S. Bianchi, R. Bigazzi, A. Caiazza, and V.M. Campese A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 2003 565 570
42. J.E. Sidaway, R.G. Davidson, F. McTaggart, T.C. Orton, R.C. Scott, and G.J. Smith Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells J Am Soc Nephrol 15 2004 2258 2265
43. P. Villa, M. Jiménez, M.C. Soriano, J. Manzanares, and P. Casasnovas Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients Crit Care 9 2005 R139 R143